on September 23, 2004
Published online before print September 23, 2004, doi: 10.1161/01.ATV.0000146325.93749.a8
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on July 20, 2004
Accepted on September 15, 2004
High-Density Lipoprotein Subpopulation Profile and Coronary Heart Disease. Prevalence in Male Participants of the Framingham Offspring Study
Bela F. Asztalos *;
From the Lipid Metabolism Laboratory (B.F.A., K.V.H., C.E.C., M.C.B., E.J.S.), HNRCA at Tufts University, Boston, Mass; and the Department of Biostatistics (L.A.C., S.D.), Boston University, Boston, Mass.
* To whom correspondence should be addressed. E-mail: bela.asztalos{at}tufts.edu.
Objective--High-density lipoprotein (HDL) is a heterogeneous lipoprotein class and there is no consensus on the value of HDL subspecies in coronary heart disease (CHD) risk assessment. We tested the hypothesis whether specific HDL subpopulations are significantly associated with CHD-prevalence.
Methods and Results--ApoA-I concentrations (mg/dL) in HDL subpopulations were quantitatively determined by native 2d gel electrophoresis, immunoblotting, and image analysis in male participants in the Framingham Offspring Study (FOS). CHD cases (n=169) had higher pre
-1 and 
-3 particle and lower -1, pre-3, and pre-1 particle levels than either all (n=1277) or HDL cholesterol-matched (n=358) controls. -1 and pre-3 levels had an inverse association, whereas -3 and pre-1 particle levels had a positive association with CHD prevalence after adjusting the data for established CHD risk factors. Standardized logit coefficients indicated that -1 HDL was most significantly associated with CHD prevalence. Moreover, each mg/dL increase in -1 particle level decreased odds of CHD by 26% (P<0.0001), whereas each mg/dL increase in HDL cholesterol decreased odds of CHD by 2% in a model including all established CHD risk factors.
Conclusion-- Specific HDL subpopulations were positively correlated, whereas others were inversely correlated with CHD prevalence in male subject in the FOS, indicating that the various HDL particles might have different roles in the cause of CHD.
Key words: lipoproteins • high-density lipoprotein cholesterol • high-density lipoprotein subpopulations • apolipoprotein A-I • coronary heart disease
This article has been cited by other articles:
 |
|
 |
|
  E. J. Schaefer, J. A. Gleason, and M. L. Dansinger Dietary Fructose and Glucose Differentially Affect Lipid and Glucose Homeostasis J. Nutr., June 1, 2009; 139(6): 1257S - 1262S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Kostapanos, H. J. Milionis, T. D. Filippatos, L. G. Christogiannis, E. T. Bairaktari, A. D. Tselepis, and M. S. Elisaf Dose-dependent Effect of Rosuvastatin Treatment on HDL-subfraction Phenotype in Patients With Primary Hyperlipidemia Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2009; 14(1): 5 - 13. [Abstract] [PDF]
|
|
|
|
 |
|
 J. Juarez-Rojas, A. Medina-Urrutia, R Posadas-Sanchez, E Jorge-Galarza, E Mendoza-Perez, N Caracas-Portilla, G Cardoso-Saldana, G Munoz-Gallegos, and C Posadas-Romero High-density lipoproteins are abnormal in young women with uncomplicated systemic lupus erythematosus Lupus, November 1, 2008; 17(11): 981 - 987. [Abstract] [PDF]
|
|
|
|
 |
|
 R. Movva and D. J. Rader Laboratory Assessment of HDL Heterogeneity and Function Clin. Chem., May 1, 2008; 54(5): 788 - 800. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Kaess, M. Fischer, A. Baessler, K. Stark, F. Huber, W. Kremer, H. R. Kalbitzer, H. Schunkert, G. Riegger, and C. Hengstenberg The lipoprotein subfraction profile: heritability and identification of quantitative trait loci J. Lipid Res., April 1, 2008; 49(4): 715 - 723. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-M. Chardigny, F. Destaillats, C. Malpuech-Brugere, J. Moulin, D. E Bauman, A. L Lock, D. M Barbano, R. P Mensink, J.-B. Bezelgues, P. Chaumont, et al. Do trans fatty acids from industrially produced sources and from natural sources have the same effect on cardiovascular disease risk factors in healthy subjects? Results of the trans Fatty Acids Collaboration (TRANSFACT) study Am. J. Clinical Nutrition, March 1, 2008; 87(3): 558 - 566. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Lamon-Fava, D. M. Herrington, D. M. Reboussin, M. Sherman, K. V. Horvath, L. A. Cupples, C. White, S. Demissie, E. J. Schaefer, and B. F. Asztalos Plasma Levels of HDL Subpopulations and Remnant Lipoproteins Predict the Extent of Angiographically-Defined Coronary Artery Disease in Postmenopausal Women Arterioscler Thromb Vasc Biol, March 1, 2008; 28(3): 575 - 579. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. D. Santos, E. J. Schaefer, B. F. Asztalos, E. Polisecki, J. Wang, R. A. Hegele, L. R. C. Martinez, M. H. Miname, C. E. Rochitte, P. L. Da Luz, et al. Characterization of high density lipoprotein particles in familial apolipoprotein A-I deficiency J. Lipid Res., February 1, 2008; 49(2): 349 - 357. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Kontush and M. J. Chapman Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis Pharmacol. Rev., September 1, 2006; 58(3): 342 - 374. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Mineo, H. Deguchi, J. H. Griffin, and P. W. Shaul Endothelial and Antithrombotic Actions of HDL Circ. Res., June 9, 2006; 98(11): 1352 - 1364. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. F. Asztalos, M. de la Llera-Moya, G. E. Dallal, K. V. Horvath, E. J. Schaefer, and G. H. Rothblat Differential effects of HDL subpopulations on cellular ABCA1- and SR-BI-mediated cholesterol efflux J. Lipid Res., October 1, 2005; 46(10): 2246 - 2253. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. F. Asztalos, D. Collins, L. A. Cupples, S. Demissie, K. V. Horvath, H. E. Bloomfield, S. J. Robins, and E. J. Schaefer Value of High-Density Lipoprotein (HDL) Subpopulations in Predicting Recurrent Cardiovascular Events in the Veterans Affairs HDL Intervention Trial Arterioscler Thromb Vasc Biol, October 1, 2005; 25(10): 2185 - 2191. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Krimbou, H. Hajj Hassan, S. Blain, S. Rashid, M. Denis, M. Marcil, and J. Genest Biogenesis and speciation of nascent apoA-I-containing particles in various cell lines J. Lipid Res., August 1, 2005; 46(8): 1668 - 1677. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Hajj Hassan, S. Blain, B. Boucher, M. Denis, L. Krimbou, and J. Genest Structural modification of plasma HDL by phospholipids promotes efficient ABCA1-mediated cholesterol release J. Lipid Res., July 1, 2005; 46(7): 1457 - 1465. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Bruckert, R. Pamphile, F. McCoy, and P. Andre Defining the prevalence of low HDL-C in a European cohort of dyslipidaemic patients Eur. Heart J. Suppl., July 1, 2005; 7(suppl_F): F23 - F26. [Abstract] [Full Text] [PDF]
|
|